Clinical Trial Update: Voltaren Emulgel 2% Acute Ankle Sprain Non Inferiority Study [Phase 3]

View source ↗

Summary

Phase 3 non-inferiority trial update for Voltaren Emulgel 2% in acute ankle sprain; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankle Sprain
• Pain

Drugs mentioned

• Voltaren Emulgel 2% (diclofenac)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pain | Phase 3 | Status: COMPLETED | Results posted: 2022-04-12